Basel, 24 November 2025: Medartis Holding AG, a leading orthopaedic company specialising in head and extremity surgery, announces today that its Board has appointed Dr Peter Hackel as new Chief…
Your gateway to the Medartis knowledge world: Medartis ONE brings together product information, educational resources, and marketing materials in one central platform. Fast, intuitive, and always…
Jonathan Tueting, MD of Rush Orthopaedics & Sports Medicine in Aurora, Illinois performed the very first carpometacarpal (CMC) total joint arthroplasty in the United States this week using the TOUCH®…
Medartis reported total sales of CHF 123.0 million for H1 2025, representing growth of 14.1% at constant exchange rates (CER). Core sales reached CHF 122.1 million with organic growth of 15.3%. EMEA…
Following FDA approval of the KeriMedical TOUCH prosthesis on 10 July, the Medartis Group has decided to acquire the remaining 53% of the privately held company in accordance with the existing…
The shareholders of Medartis Holding AG (SIX: MED) today approved all the substantive proposals of the Board of Directors with significant majority exceeding 94.0%. All members of the Board of…
Medartis today reported total sales of CHF 224.8 million for the full year 2024, representing growth of 8.5% at constant exchange rates (CER). Core sales increased 11.7% and reached CHF 219.6 million.…
The New Medartis Global Website Is Live! We are thrilled to introduce our brand-new Medartis website—a significant step in our customer experience! This platform is more than just a redesign; it’s a…
Medartis today announced that its Board has appointed Matthias Schupp to the position of CEO, joining Medartis by the beginning of November. Matthias will succeed Christoph Brönnimann, who will ensure…
